I had the honor of serving as the DSSS team's subject matter expert for Rave EDC and its integrations in the past. However, I now have the privilege of leading a diverse group of talented senior developers and user access management professionals within the DSSS team. By working together, we aim to deliver innovative solutions that optimize clinical trial performance and drive positive outcomes for our study teams.
I've met Christian Luginsland - Head of Business Excellence & Innovation, DS&AI F2F Event, Madrid 2023
2023-05-03
Thank you for being open and honest with feedback.
I've met Friederike at Bayer's DS&AI Meeting in Madrid May 2023
I've met Friederike during the DS&AI meeting in May 2023 in Madrid. She works within Data Strategy and Governance in the group Proprietary Information Management.
Lucky you! It's not every day that you meet the one and only Hans, leader of the amazing Value, Engagement & Training team, passionately driving digital transformation, strategy, value, portfolio and continuous learning in Bayer Pharma R&D. Situational leadership, empathy, collaboration and transparency are among his core values. In his personal life he runs marathons, trains & coaches a youth football team, works in the garden, walks with his dog and enjoys his Italian/Dutch family. Pleased to meet you :-)
I am passionate about harnessing data and cutting-edge technologies to optimize the clinical impact of cancer drugs and diagnostics. Drawing from my personal experiences with cancer, I am devoted to developing analytical systems that integrate clinical, imaging, and biomarker data to provide real-time access to high-quality information. Throughout my career, I have worked closely with clinical teams, advocating for data-driven decision-making and uncovering insights into clinical realities. I strongly believe that by leveraging complex datasets, we can gain a deeper understanding of cancer biology, and subsequently improve our decision-making processes. This adaptable approach empowers us to address fundamental questions, such as which targets to pursue, which technologies to invest in, which drugs to prioritize, and ultimately, which therapies are best suited for individual patients.
Deepthi from DS3
2023-05-02
Over 15+ years of professional experience as a Product Owner/Software Business Analyst and Process Owner in Pharmaceuticals, Banking, and Health care domains. Working from India for Bayer pharmaceuticals since 2018.